First-Time Generic Release of Vimovo

First-Time Generic Release of Vimovo
Released: 03/09/2020  

The generic equivalent of Vimovo (naproxen/esomeprazole) is now available. Vimovo is FDA approved for the reduction of the risk of NSAID (non-steroidal anti-inflammatory) associated gastric ulcers in patients who require an NSAID for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in adults.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at pharmacy@carlislemedical.com.